Iressa
information and resources from the National Cancer Institute
NCI Thesaurus | Iressa
(Other name for: gefitinib)NCI Thesaurus | Iressa
(Other name for: gefitinib)
|
|
|
|
news articles
Firms Naming Common Areas After Places Mar 31, 2006
Donga, AstraZeneca, a multi-national pharmaceutical company, puts name tags reading “Iressa,� “Zoladex,� “Nexium,� and “Casodex� on meeting rooms ...
American Journal of Respiratory and Critical Care Medicine Vol 173 ... Mar 28, 2006
AJRCCM (subscription), Gefitinib (Iressa) was the first in its class to receive US Food and Drug Administration (FDA) approval in the United States and Japan, but the approval was ...
Dana Reeve, a Nonsmoker, Dies of Lung Cancer at 44 Mar 7, 2006
MedPage Today, Patients with mutations in the EGF receptor may respond to two targeted therapies, Tarceva (erlotinib) and Iressa (gefitinib), a finding that was reported by Dr ...
Early, Unproven Findings Changing Doctors' Practice Mar 14, 2006
Forbes But the authors of the new study warn that many other treatments -- for example, cox-2 painkillers or the lung cancer drug Iressa -- looked just as promising ...
Two New Cancer Drugs Discovered Mar 28, 2006
Medical News Today (press release), Growth Factor Receptors (EGFR), which are targeted by other successful agents such as trastuzamab (Herceptin), cetuximab (Erbitux) and gefitinib (Iressa). ...
Study Finds Shifts In Treatment Trends Prior To Publication Of ... Mar 17, 2006
Medical News Today (press release), They present the story of Iressa (gefitinib), a drug used for treating lung cancer, prescribed based on early studies that didn't have control groups and that ...
Adopt Knowledge from This Analysis to Drive Strategic Planning ... Mar 25, 2006
New Age Media Concepts (press release) Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. ...
Genes May Influence Response to Brain-Tumor Treatments Feb 26, 2006
Online - International News Network, Two drugs, Tarceva (erlotinib) and Iressa (gefitinib), have had some success in treating glioblastomas and have been approved for treating advanced lung cancer ...
Experts: Nonsmoker's death from lung cancer isn't unusual Mar 7, 2006
The State, The trade names of the drugs are Tarceva, Iressa and Xyotax. Iressa is prescribed only to a limited group of patients who have already responded well to it. ...
Dropping GSK for AZ is a bold move but the time is right to make ... Mar 17, 2006
Times Online, More than £30 billion was wiped off the company’s value as first Exanta, the blood thinner, and then Iressa, a lung cancer treatment, failed to get the nod ...
Oncologists Jumped Gun on Taxanes After Oral Presentation Mar 17, 2006
MedPage Today, They cited the case of Iressa (gefitinib), where preliminary results presented at a meeting did not stand up in a large placebo-controlled trial. ...
AstraZeneca's outgoing CEO got 60% pay hike in 2005 Feb 28, 2006
MarketWatch ...million, compared with GBP1.411 million in 2004 when his remuneration was cut following setbacks with the company's anticoagulant Exanta and cancer drug Iressa ...
Dana Reeve's Death Draws Attention to Lung Cancer Mar 15, 2006
International News Service, New chemotherapy agents and targeted drugs like Iressa and Tarceva have improved survival rates over the past decade, Patel said, but researchers still have a ...
Gene test offers hope for brain cancer patients Mar 15, 2006
Standard-Speaker, Other targeted drugs include the breast cancer treatment Herceptin, which is given only to women whose key gene is overactive, and Iressa, a drug scientists ...
New Therapies Target Cancer Mar 7, 2006
Drug Discovery & Development (subscription), A number of other targeted kinase therapies came in the wake of Gleevec, including Iressa (gefitinib) from AstraZenenca Pharmaceuticals, Wilmington, Del ...
Iressa Has Little Effect on Advanced Breast Cancer: Presented at ... Dec 13, 2005
DG News SAN ANTONIO, TX -- December 13, 2005 -- Hormone-resistant breast cancers do not appear to respond to treatment with Iressa (gefitinib), according to results of ...
Results Encouraging with Interferon Alpha Plus Iressa (Gefitinib) ... Nov 22, 2005
DG News PHILADELPHIA, PA -- November 22, 2005 -- In a phase 2 study of interferon alpha (IFN) plus either Gleevec (imatinib mesylate) or Iressa (gefitinib) in patients ...
HEALTH: Experts to create genetic map of cancer Dec 18, 2005
Daily Times, A handful of so-called targeted drugs — Herceptin, Gleevec, Iressa, Tarceva — are proving remarkably effective at battling certain cancers in patients with ...
Rush University Medical Center Studies New Agent To Treat Lung ... Dec 15, 2005
PharmaLive.com (press release), ...rate in patients with advanced BAC who have progressed after treatment with up to two previous rounds of chemotherapy, one of which must be Iressa(R) or Tarceva ...
US speeding up cancer research Dec 14, 2005
Gainesville Sun, A handful of drugs - Herceptin, Gleevec, Iressa, Tarceva - are proving remarkably effective at battling cancers in patients with specific faulty genes. ...
Breakthrough Pancreatic Cancer Research Dec 14, 2005
13WHAM-TV, In those treated first with surgery, Ahmad's team is testing called Iressa, a chemotherapy drug never available for pancreatic cancer trials before. ...
EU experts back Astra cancer drug "orphan" status Dec 14, 2005
Reuters ...could help Europe's third largest drug maker recover some of the ground it lost in oncology last year when its marketed lung cancer treatment Iressa failed in ...
Lung cancer in women Dec 11, 2005
ITP.net, Researchers have found that lung cancer patients with mutations in EGFR tend to respond better to Iressa, one of the newer, targeted cancer therapies. ...
Fit, older lung cancer patients respond to chemotherapy Dec 18, 2005
St. Petersburg Times, New targeted therapeutic agents such as Iressa and Tarceva (and other similar targeted agents) which could be very effective in selected patients, while being ...
US launches cancer gene mapping project Dec 13, 2005
Reuters ...in some cases of ovarian cancer, the p53 gene involved in many different tumors, and the EGFR gene targeted by AstraZeneca Plc's Iressa and Genentech and OSI ...
New Effort Aims to Unlock Secrets of Cancer Genes Dec 13, 2005
New York Times, Some studies have shown that the lung cancer drug Iressa is likely to work very well for about 10 percent of patients with a particular mutation but barely at ...
New Genome Project to Focus on Genetic Links in Cancers Dec 13, 2005
New York Times, Some studies have shown that the lung cancer drug Iressa is likely to work very well for the 10 percent of patients who have a particular type of mutation but ...
Cancer gene map aims to defang dread diagnosis Dec 13, 2005
Arizona Daily Star, ...genes involved in certain cancers, have led to the development of several new drugs, such as Herceptin for some forms of breast cancer and Iressa for some lung ...
Experts to Create Genetic Map of Cancer Dec 13, 2005
Leading The Charge, ...cancer patients have the genetic aberration that Herceptin targets, and just 10 percent of lung cancer sufferers harbor the mutation that Iressa and Tarceva ...
Gene mapping project promises new targeted cancer therapies Dec 14, 2005
News-Medical.net, ...implicated in some cases of ovarian cancer, the p53 gene involved in many different tumours, and the EGFR gene targeted by AstraZeneca's Iressa and Genentech ...
New Data Show Survival Benefit for Arimidex(TM) in Early Breast ... Dec 9, 2005
news aktuell (Pressemitteilung), CASODEX' (bicalutamide), 'FASLODEX' (fulvestrant), 'NOLVADEX' (tamoxifen), 'ZOLADEX' (goserelin), 'TOMUDEX' (raltitrexed) and 'IRESSA' (gefitinib) as well as a ...
EU Committee for Orphan Medicinal Products Recommends Orphan Drug ... Dec 14, 2005
news aktuell (Pressemitteilung), Oncology, Tel: +44-(0)1625-232685, Mobile: +44-(0)-7747-118-498, Peter.S.Edwards@astrazeneca.com; Janet Milton-Edwards, Global PR Director - IRESSA & ZACTIMA ...
Researchers probe links between gender and cancer Dec 8, 2005
Pittsburgh Post Gazette, He cites an example in lung cancer, when studies of Iressa, a targeted therapy for lung cancer, showed that patients with a particular genetic mutation ...
AstraZeneca set to acquire first brand soon Dec 14, 2005
Sify, The weeks-old entrants are Casodex for prostate cancer and Iressa for lung cancer, which means five of the parent company's seven oncology brands have now come ...
AZ shares boosted by cancer trial Nov 23, 2005
Times Online, It could also help AstraZeneca to regain some of the ground it lost when trials of Iressa, another late-stage medicine against lung cancer, showed little ...
AstraZeneca starts lung cancer drug study Nov 23, 2005
Life Style Extra, ...a successful trial of the anti-cancer compound will help it recoup lost ground following last year's failure of marketed lung cancer treatment Iressa in an ...
Heading Off Heart Attacks Dec 12, 2005
TechnologyReview.com Earlier this year, for example, scientists discovered a key SNP that makes the cancer drugs Iressa and Tarceva much more effective in people who carry the ...
UPDATE 1-Astra starts key study for new lung cancer drug Nov 23, 2005
Reuters ...cancer compounds that could help AstraZeneca recover some of the ground it lost in oncology last year when its marketed lung cancer treatment Iressa failed in ...
AstraZeneca helps FTSE to new high Nov 23, 2005
Guardian Unlimited, Investors hope the drug will help AstraZeneca to recover some of the ground it lost after a setback last year, when its cancer drug, Iressa, failed in trials ...
AEterna Zentaris appoints a Board Vice Chairman, a New Chair of ... Nov 21, 2005
Yahoo! News (press release) ...he was involved in the early development of many of the agents now used routinely, including: Paclitaxel, Docetaxel, Gemcitabine, CPT-11, Iressa and Tarceva. ...
Pharma Reformulates Dec 5, 2005
Chemical & Engineering News ...deficit hyperactivity disorder (ADHD) drug Strattera, Johnson & Johnson's (J&J) heart failure drug Natrecor, and AstraZeneca's lung cancer treatment Iressa. ...
Drugs' side effects need checks Nov 25, 2005
Daily Yomiuri Online, ...harmful side effects. Iressa, a drug used to treat lung cancer, has side effects that led to the death of some patients. With clinical ...
Pfizer's Troubles Pull Down Drugmakers Nov 21, 2005
Chemical & Engineering News ...version of the same drug; the cardiovascular drug Plendil, which is suffering from generic competition in the US; and the cancer treatment Iressa, which US ...
|
|
